Brokers Suggest Investing in Celestica (CLS): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Celestica: The Hidden Winner Behind AI CapEx
Celestica's Q1 FY 2025 HPS revenue surged 99% YoY to $1B, now representing 39% of total company revenue. Full-year FY 2025 revenue guidance was raised to $10.85B, supported by 800G momentum and 1.6T switch program wins. The PEG ratio (GAAP, TTM) of 0.9x highlights undervaluation relative to 48.9% YoY EBIT growth vs. the sector's 11.3%.
Celestica (CLS) Stock Sinks As Market Gains: Here's Why
In the closing of the recent trading day, Celestica (CLS) stood at $119.90, denoting a -1.12% change from the preceding trading day.
CLS Outpaces Industry in the Past 3 Months: Reason to Buy the Stock? (Revised)
CLS surges 24.3% in 3 months, outpacing peers as AI-fueled demand lifts its data center and networking solutions.
Is Most-Watched Stock Celestica, Inc. (CLS) Worth Betting on Now?
Celestica (CLS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Celestica (CLS) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Celestica (CLS) closed at $116.37, marking a -1.48% move from the previous day.
Celestica: The AI Party May Be Ending
Celestica's stock has massively outperformed since 2022, but current valuations mirror Dot-com 2000 bubble extremes, making the risk/reward balance unattractive. Valuation metrics have surged: high P/E and price-to-sales ratios, matched with ultra-low free cash flow yield, now require continued high-growth rates to justify current pricing. Insider selling has been significant (especially above $120), with management dumping most of their shares during 2024–25, signaling a lack of confidence in further upside.
Wall Street Bulls Look Optimistic About Celestica (CLS): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Celestica - Finally An AI Play That Is Not Trading At Too Elevated Valuations
Celestica is a lesser-known AI hardware and supply chain play, offering exposure to AI trends without high risk or overvaluation. Despite a low gross profit margin, CLS boasts strong ROE and exceptional revenue and EBITDA growth, outpacing industry averages and peers. Valuation is attractive: CLS trades at lower EV/EBITDA and P/S ratios than most AI peers, with growth prospects superior to similarly valued companies.
Celestica vs. Plexus: Which EMS Stock is a Better Bet Right Now?
CLS is riding on growing demand for its 400G and 800G switches in AI applications, while PLXS is witnessing strong demand in healthcare and semicap verticals.
Celestica: Continue Walking The Bull Trail
Celestica's robust growth is fueled by surging demand for hardware platform solutions, especially networking switches for hyperscalers. Recent US-China tariff reductions are a major positive catalyst, likely paving the way for future guidance upgrades, as management had earlier assumed no changes to tariff policies. Valuations are at a premium vs peers, but the risk here has eased slightly, as CLS stock today is at a lower premium vs peers than it was months ago.
Here is Why Growth Investors Should Buy Celestica (CLS) Now
Celestica (CLS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
